+ 0.70
+ 0.47%

IM Cannabis' German Subsidiary To Import 4,000 Kg Of Marijuana Products

May 20, 2020 1:45 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
IM Cannabis' German Subsidiary To Import 4,000 Kg Of Marijuana Products

Israel medical cannabis producer IM Cannabis (CSE:IMCC) achieved another milestone in bolstering the presence of its branded products in the European market.

This week, the company announced its EU-GMP German subsidiary, Adjupharm GmbH, secured an extension to its license from the German medical regulator for the import of 4,000 kilograms of dry flower and extracts.

The license allows IMC to import from various countries such as Spain, Portugal the Netherlands, and Canada, both bulk and end-products including dry flower, dronabinol and extracts. Furthermore, the license enables IMC to fulfill binding sales agreements the company recently signed with three German distributors.

“The ability to diversify the sources in which we import our branded products into the German market is a significant strategic advantage," Oren Shuster, co-founder and CEO of IM Cannabis, said. "It enables IMC to move forward in meeting the current and future growing demand for medical cannabis in Germany. It also provides the peace of mind and confidence to our distributor partners that we deliver on our contractual obligations and beyond.”

Don’t miss this opportunity to connect with THE cannabis movers and shakers from across the globe during Benzinga’s first Virtual Cannabis Capital Conference on June 1.

Photo by Javier Hasse.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.

Related Articles

The Week In Cannabis: Tilray's Huge Week, Colin Hanks, Allen Iverson, Seth Rogen And More

Below is a recap of the main news related to the cannabis industry and markets for the week ending July 30, 2021. Contents read more

IM Cannabis Doubles Down On Israeli Cannabis Market With Two Acquisitions For $3.7M

Multi-country operator IM Cannabis (CSE: IMCC) (NASDAQ: IMCC), one of Israel’s pioneering medical cannabis companies with operations in Canada and Germany, announced a string of acquisitions this week that further expand its footprint in the fast-growing Israeli medical cannabis read more

The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More

Cannabis stocks traded mostly in the green this week, as we got into earnings season. read more

The Week In Cannabis: Glass House, Canopy, Curaleaf, Trulieve, Virginia And More

In a week where overall markets traded up, cannabis stocks were in the red, despite a series of big news, M&A and financing announcements. read more